<?xml version="1.0" encoding="UTF-8"?>
<p id="P63">Interferons are also approved as intralesional therapy for condyloma acuminatum of genital and perianal areas.
 <sup>
  <xref ref-type="bibr" rid="R136">136</xref>
 </sup> Intralesional injection ensures relatively high concentrations of IFN at the local site of infection, but occurrence of systemic adverse effects suggests its absorption from this site. Currently, HSV is generally treated with acyclovir, but beneficial responses to topical IFN-α have been reported for genital herpes
 <sup>
  <xref ref-type="bibr" rid="R137">137</xref>
 </sup> and HSV keratitis.
 <sup>
  <xref ref-type="bibr" rid="R90">90</xref>
 </sup> Beneficial responses to IFN-α have been reported for HIV-associated progressive multifocal leukoencephalopathy
 <sup>
  <xref ref-type="bibr" rid="R138">138</xref>
 </sup>; however, these findings are debatable because IFN-α may not provide added benefits when used with highly active antiretroviral therapy.
 <sup>
  <xref ref-type="bibr" rid="R139">139</xref>
 </sup>
</p>
